Monoclonal Antibodies Market Report by Production Method (In Vivo, In Vitro), Source (Murine, Chimeric, Humanized, Human), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, and Others), End Use (Hospitals, Research Institutes, and Others), and Region 2025-2033

Monoclonal Antibodies Market Report by Production Method (In Vivo, In Vitro), Source (Murine, Chimeric, Humanized, Human), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, and Others), End Use (Hospitals, Research Institutes, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6278

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Monoclonal Antibodies Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Production Method
    6.1    In Vivo
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    In Vitro
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Source
    7.1    Murine
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Chimeric
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Humanized
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Human
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Indication
    8.1    Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Autoimmune Diseases
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Inflammatory Diseases
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Infectious Diseases
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by End Use
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Research Institutes
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AbbVie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Amgen Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Biogen Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche AG
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
        15.3.5    GSK plc
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Johnson & Johnson
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Merck KGaA
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Novartis AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Novo Nordisk A/S
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Sanofi S.A.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Thermo Fisher Scientific Inc.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Monoclonal Antibodies Market: Major Drivers and Challenges
Figure 2: Global: Monoclonal Antibodies Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Monoclonal Antibodies Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Monoclonal Antibodies Market: Breakup by Production Method (in %), 2024
Figure 5: Global: Monoclonal Antibodies Market: Breakup by Source (in %), 2024
Figure 6: Global: Monoclonal Antibodies Market: Breakup by Indication (in %), 2024
Figure 7: Global: Monoclonal Antibodies Market: Breakup by End Use (in %), 2024
Figure 8: Global: Monoclonal Antibodies Market: Breakup by Region (in %), 2024
Figure 9: Global: Monoclonal Antibodies (In Vivo) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Monoclonal Antibodies (In Vivo) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Monoclonal Antibodies (In Vitro) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Monoclonal Antibodies (In Vitro) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Monoclonal Antibodies (Murine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Monoclonal Antibodies (Murine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Monoclonal Antibodies (Chimeric) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Monoclonal Antibodies (Chimeric) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Monoclonal Antibodies (Humanized) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Monoclonal Antibodies (Humanized) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Monoclonal Antibodies (Human) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Monoclonal Antibodies (Human) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Monoclonal Antibodies (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Monoclonal Antibodies (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Monoclonal Antibodies (Autoimmune Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Monoclonal Antibodies (Autoimmune Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Monoclonal Antibodies (Inflammatory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Monoclonal Antibodies (Inflammatory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Monoclonal Antibodies (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Monoclonal Antibodies (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Monoclonal Antibodies (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Monoclonal Antibodies (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Monoclonal Antibodies (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Monoclonal Antibodies (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Monoclonal Antibodies (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Monoclonal Antibodies (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Monoclonal Antibodies (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Monoclonal Antibodies (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: North America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: North America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: United States: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: United States: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Canada: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Canada: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Asia-Pacific: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Asia-Pacific: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: China: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: China: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Japan: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Japan: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: India: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: India: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: South Korea: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: South Korea: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Australia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Australia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Indonesia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Indonesia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Europe: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Europe: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Germany: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Germany: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: France: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: France: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: United Kingdom: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: United Kingdom: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Italy: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Italy: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Spain: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Spain: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Russia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Russia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Latin America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Latin America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Brazil: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Brazil: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Mexico: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Mexico: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Middle East and Africa: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Middle East and Africa: Monoclonal Antibodies Market: Breakup by Country (in %), 2024
Figure 85: Middle East and Africa: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Global: Monoclonal Antibodies Industry: SWOT Analysis
Figure 87: Global: Monoclonal Antibodies Industry: Value Chain Analysis
Figure 88: Global: Monoclonal Antibodies Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Monoclonal Antibodies Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Monoclonal Antibodies Market Forecast: Breakup by Production Method (in Million USD), 2025-2033
Table 3: Global: Monoclonal Antibodies Market Forecast: Breakup by Source (in Million USD), 2025-2033
Table 4: Global: Monoclonal Antibodies Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 5: Global: Monoclonal Antibodies Market Forecast: Breakup by End Use (in Million USD), 2025-2033
Table 6: Global: Monoclonal Antibodies Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Monoclonal Antibodies Market: Competitive Structure
Table 8: Global: Monoclonal Antibodies Market: Key Players

Monoclonal Antibodies Market Report by Production Method (In Vivo, In Vitro), Source (Murine, Chimeric, Humanized, Human), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, and Others), End Use (Hospitals, Research Institutes, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials